Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I E Smith

Showing results (131-140 of 371) with videos related to

Pageof 38
Sort By:
Journal of Sleep Research|April 4, 2001
Health-related quality of life in narcolepsyE Daniels, M A King, I E Smith, et al.
Lancet (London, England)|February 25, 1995
Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancerM Dowsett, S R Johnston, T J Iveson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1984
Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapyM Dowsett, A L Harris, I E Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
A phase II clinical study of mAMSA in small cell carcinoma of the lungP J Dady, A P Sappino, A Rudd, et al.
Lancet (London, England)|July 28, 1984
Cardiotoxicity associated with mitoxantroneR Stuart-Harris, M Pearson, I E Smith, et al.
European Journal of Neurology|February 2, 2010
Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorderK N Anderson, A Vincent, I E Smith, et al.
British Journal of Urology|October 1, 1977
Metastatic orchioblastoma: alpha1-fetoprotein in diagnosis and combination chemotherapy in treatment: a case reportI E Smith, H B Eckstein, J Kohn, et al.
The Journal of Pediatrics|September 1, 1984
Neonatal ethanol withdrawal: characteristics in clinically normal, nondysmorphic neonatesC D Coles, I E Smith, P M Fernhoff, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Aminoglutethimide dose and hormone suppression in advanced breast cancerA L Harris, M Dowsett, S L Jeffcoate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancerJ C Newby, S R Johnston, I E Smith, et al.
Pageof 38

Showing results (131-140 of 371) with videos related to

Sort By:
Pageof 38
Journal of Sleep Research|April 4, 2001
Health-related quality of life in narcolepsyE Daniels, M A King, I E Smith, et al.
Lancet (London, England)|February 25, 1995
Response to specific anti-oestrogen (ICI182780) in tamoxifen-resistant breast cancerM Dowsett, S R Johnston, T J Iveson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1984
Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapyM Dowsett, A L Harris, I E Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
A phase II clinical study of mAMSA in small cell carcinoma of the lungP J Dady, A P Sappino, A Rudd, et al.
Lancet (London, England)|July 28, 1984
Cardiotoxicity associated with mitoxantroneR Stuart-Harris, M Pearson, I E Smith, et al.
European Journal of Neurology|February 2, 2010
Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorderK N Anderson, A Vincent, I E Smith, et al.
British Journal of Urology|October 1, 1977
Metastatic orchioblastoma: alpha1-fetoprotein in diagnosis and combination chemotherapy in treatment: a case reportI E Smith, H B Eckstein, J Kohn, et al.
The Journal of Pediatrics|September 1, 1984
Neonatal ethanol withdrawal: characteristics in clinically normal, nondysmorphic neonatesC D Coles, I E Smith, P M Fernhoff, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Aminoglutethimide dose and hormone suppression in advanced breast cancerA L Harris, M Dowsett, S L Jeffcoate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancerJ C Newby, S R Johnston, I E Smith, et al.
Pageof 38